citation information (apr 2008, from ISI web of knowledge)
56. Kim WJ, Bae SC
Molecular biomarkers in urothelial bladder cancer
CANCER SCIENCE Volume: 99 Issue: 4 Pages: 646-652 Published: APR 2008
55. Devany M, Kappes F, Chen KM, et al.
Solution NMR structure of the N-terminal domain of the human DEK protein
PROTEIN SCIENCE Volume: 17 Issue: 2 Pages: 205-215 Published: FEB 2008
54. Paderova JA, Orlic-Milacic M, Yoshirnoto M, et al.
Novel 6p rearrangements and recurrent translocation breakpoints in retinoblastoma cell lines identified by spectral karyotyping and mBAND analyses
CANCER GENETICS AND CYTOGENETICS Volume: 179 Issue: 2 Pages: 102-111 Published: DEC 2007
53. Bielenberg DR, Klagsbrun M
Targeting endothelial and tumor cells with semaphorins
CANCER AND METASTASIS REVIEWS 26 (3-4): 421-431 DEC 2007
52. Hurtado M, Lozano JJ, Castellanos E, et al.
Activation of the epidermal growth factor signalling pathway by tissue plasminogen activator in pancreas cancer cells
GUT 56 (9): 1266-1274 SEP 2007
51. Kawakami K, Enokida H, Tachiwada T, et al.
Increased SKP2 and CKS1 gene expression contributes to the progression of human urothelial carcinoma
JOURNAL OF UROLOGY 178 (1): 301-307 JUL 2007
50. Roskoski R
Vascular endothelial growth factor (VEGF) signaling in tumor progression
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 62 (3): 179-213 JUN 2007
49. Matsui S, Ito M, Nishiyama H, et al.
Genomic characterization of multiple clinical phenotypes of cancer using multivariate linear regression models
BIOINFORMATICS 23 (6): 732-738 MAR 15 2007
48. Ewis AA, El-Samman E, Ali N, et al.
Gene expression profile in squamous cell carcinoma of the urinary bladder using complementary deoxyribonucleic acid microarray
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS 25 (2): 120-127 MAR-APR 2007
47. Dyrskjot L, Zieger K, Orntoft TF
Recent advances in high-throughput molecular marker identification for superficial and invasive bladder cancers
FRONTIERS IN BIOSCIENCE 12: 2063-2073 JAN 1 2007
46. He M, Rosen J, Mangiameli D, et al.
Cancer development and progression
ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 593: 117-133 2007
45. Menqual L, Burset M, Ars E, et al.
Partially degraded RNA from bladder washing is a suitable sample for studying gene expression profiles in bladder cancer
EUROPEAN UROLOGY 50 (6): 1347-1356 DEC 2006
44. Wise-Draper TM, Allen HV, Jones EE, et al.
Apoptosis inhibition by the human DEK oncoprotein involves interference with p53 functions
MOLECULAR AND CELLULAR BIOLOGY 26 (20): 7506-7519 OCT 2006
43. Feng QH, Yu MJ, Kiviat NB
Molecular biomarkers for cancer detection in blood and bodily fluids
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES 43 (5-6): 497-560 SEP-DEC 2006
42. Pavlidis P, Poirazi P
Research article - Individualized markers optimize class prediction of microarray data
BMC BIOINFORMATICS 7: Art. No. 345 JUL 14 2006
41. Wu QO, Hoffmann MJ, Hartmann FH, et al.
Amplification and overexpression of the ID4 gene at 6p22.3 in bladder cancer
MOLECULAR CANCER 4: Art. No. 16 MAY 5 2005
40.
Kawakami K, Enokida H, Tachiwada T, et al.
Identification of differentially expressed genes in human bladder cancer
through genome-wide gene expression profiling
ONCOLOGY REPORTS 16 (3): 521-531 SEP 2006
39
Tomlins SA, Mehra R, Rhodes DR, et al.
Whole transcriptome amplification for gene expression profiling and
development of molecular archives
NEOPLASIA 8 (2): 153-162 FEB 2006
38
Wu Z, Siadaty MS, Riddick G, et al.
A novel method for gene expression mapping of metastatic competence in
human bladder cancer
NEOPLASIA 8 (3): 181-189 MAR 2006
37
Egawa S, Kuruma H
Search for biomarkers of aggressiveness in bladder cancer
EUROPEAN UROLOGY 50 (1): 20-22 JUL 2006
36
Carro MS, Spiga FM, Quarto M, et al.
DEK expression is controlled by E2F and deregulated in diverse tumor
types
CELL CYCLE 5 (11): 1202-1207 JUN 1 2006
35
Lu F, Dai DL, Martinka M, et al.
Nuclear ING2 expression is reduced in human cutaneous melanomas
BRITISH JOURNAL OF CANCER 95 (1): 80-86 JUL 3 2006
34
Spiess PE, Czerniak B
Dual-track pathway of bladder carcinogenesis - Practical implications
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE 103 (6):
844-852 JUN 2006
33
Ellis LM
The role of neuropilins in cancer
MOLECULAR CANCER THERAPEUTICS 5 (5): 1099-1107 MAY 2006
32
Lindgren D, Liedberg F, Andersson A, et al.
Molecular characterization of early-stage bladder carcinomas by
expression profiles, FGFR3 mutation status, and loss of 9q
ONCOGENE 25 (18): 2685-2696 APR 2006
31
Russell M, Berardi P, Gong W, et al.
Grow-ING, Age-ING and Die-ING: ING proteins link cancer, senescence
and apoptosis
EXPERIMENTAL CELL RESEARCH 312 (7): 951-961 APR 15 2006
30
Mhawech-Fauceglia P, Cheney RT, Schwaller J
Genetic alterations in urothelial bladder carcinoma - An updated review
CANCER 106 (6): 1205-1216 MAR 15 2006
29
Knowles MA
Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?
CARCINOGENESIS 27 (3): 361-373 MAR 2006
28
Sanchez-Carbayo M, Socci ND, Lozano J, et al.
Defining molecular profiles of poor outcome in patients with invasive bladder cancer
using oligonucleotide microarrays
JOURNAL OF CLINICAL ONCOLOGY 24 (5): 778-789 FEB 10 2006
27
Sanchez-Carbayo M, Socci ND, Lozano JJ, et al.
Profiling bladder cancer using targeted antibody arrays
AMERICAN JOURNAL OF PATHOLOGY 168 (1): 93-103 JAN 2006
26
Ruutu M, Johansson B, Grenman R, et al.
Two different global gene expression profiles in cancer cell lines established from
etiologically different oral carcinomas
ONCOLOGY REPORTS 14 (6): 1511-1517 DEC 2005
25
Aaboe M, Marcussen N, Jensen KME, et al.
Gene expression profiling of noninvasive primary urothelial tumours
using microarrays
BRITISH JOURNAL OF CANCER 93 (10): 1182-1190 NOV 14
2005
24
Champelovier P, El Atifi M, Mantel F, et al.
In vitro tumoral progression of human bladder carcinoma: Role for
TGF beta
EUROPEAN UROLOGY 48 (5): 846-851 NOV 2005
23
Melissourgos ND, Kastrinakis NG, Skolarikos A, et al.
Cytokeratin-20 immunocytology in voided urine exhibits greater sensitivity and reliability
than standard cytology in the diagnosis of transitional cell carcinoma of the bladder
UROLOGY 66 (3): 536-541 SEP 2005
22
Ord JJ, Streeter EH, Roberts ISD, et al.
Comparison of hypoxia transcriptome in vitro with in vivo gene expression in human
bladder cancer
BRITISH JOURNAL OF CANCER 93 (3): 346-354 AUG 8 2005
21.
Wild PJ, Herr A, Wissmann C, et al.
Gene expression profiling of progressive papillary noninvasive carcinomas of the urinary
bladder
CLINICAL CANCER RESEARCH 11 (12): 4415-4429 JUN 15 2005
20.
Blaveri E, Simko JP, Korkola JE, et al.
Bladder cancer outcome and subtype classification by gene expression
CLINICAL CANCER RESEARCH 11 (11): 4044-4055 JUN 1 2005
19.
Eschrich S, Yang I, Bloom G, et al.
Molecular staging for survival prediction of colorectal cancer patients
JOURNAL OF CLINICAL ONCOLOGY 23 (15): 3526-3535 MAY 20 2005
18
Kim WJ, Quan CY
Genetic and epigenetic aspects of bladder cancer
JOURNAL OF CELLULAR BIOCHEMISTRY 95 (1): 24-33 MAY 1 2005
17
Chen CY, Li M, Chai H, et al.
Roles of neuropilins in neuronal development, angiogenesis, and cancers
WORLD JOURNAL OF SURGERY 29 (3): 271-275 MAR 2005
16
Ohlsson G, Moreira JMA, Gromov P, et al.
Loss of expression of the adipocyte-type fatty acid-binding protein (A-FABP) is
associated with progression of human urothelial carcinomas
MOLECULAR & CELLULAR PROTEOMICS 4 (4): 570-581 APR 2005
15
Smith SC, Oxford G, Theodorescu D
The promise of gene-expression analysis in bladder cancer: a clinician's guide
BJU INTERNATIONAL 95 (6): 874-880 APR 2005
14
Li M, Hui Y, Chai H, et al.
Pancreatic carcinoma cells express neuropilins and vascular endothelial growth factor, but
not vascular endothelial growth factor receptors
CANCER 101 (10): 2341-2350 NOV 15 2004
13.
Campos EI, Chin MY, Kuo WH, et al.
Biological functions of the ING family tumor suppressors
CELLULAR AND MOLECULAR LIFE SCIENCES 61 (19-20): 2597-2613
OCT 2004
12.
Gutierrez MI, Siraj AK, Khaled H, et al.
CpG island methylation in Schistosoma- and non-Schistosoma-associated
bladder cancer
MODERN PATHOLOGY 17 (10): 1268-1274 OCT 2004
11.
Eschrich S, Yeatman TJ
DNA microarrays and data analysis: An overview
SURGERY 136 (3): 500-503 SEP 2004
10.
Duggan B, Williamson K
Molecular markers for predicting recurrence, progression and outcomes of
bladder cancer (do the poster boys need new posters?)
CURRENT OPINION IN UROLOGY 14 (5): 277-286 SEP 2004
1.
Valdes AM, Hart DJ, Jones KA, et al.
Association study of candidate genes for the prevalence and progression of knee
osteoarthritis
ARTHRITIS AND RHEUMATISM 50 (8): 2497-2507 AUG 2004
2.
Maruya S, Kim HW, Weber RS, et al.
Gene expression screening of salivary gland neoplasms - Molecular markers of potential
histogenetic and clinical significance
JOURNAL OF MOLECULAR DIAGNOSTICS 6 (3): 180-190 AUG 2003
3.
Sanchez-Carbayo M
Recent advances in bladder cancer diagnostics
CLINICAL BIOCHEMISTRY 37 (7): 562-571 JUL 2004
4.
Li WT, Sun FZ, Grosse I
Extreme value distribution based gene selection criteria for discriminant microarray
data analysis using logistic regression
JOURNAL OF COMPUTATIONAL BIOLOGY 11 (2-3): 215-226 2004
5.
Celis JE, Gromova I, Moreira JMA, et al.
Impact of proteomics on bladder cancer research
PHARMACOGENOMICS 5 (4): 381-394 JUN 2004
6.
Mas VR, Maluf DG, Stravitz R, et al.
Hepatocellular carcinoma in HCV-infected patients awaiting liver transplantation:
Genes involved in tumor progression
LIVER TRANSPLANTATION 10 (5): 607-620 MAY 2004
7.
Dyrskjot L
Classification of bladder cancer by microarray expression profiling: towards a general
clinical use of microarrays in cancer diagnostics
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS 3 (5): 635-647 SEP 2003
8.
Sanchez-Carbayo M, Cordon-Cardo C
Applications of array technology: identification of molecular targets in bladder cancer
BRITISH JOURNAL OF CANCER 89 (12): 2172-2177 DEC 15 2003
9.
Evans AJ, Gallie BL, Jewett MAS, et al.
Defining a 0.5-Mb region of genomic gain on chromosome 6p22 in bladder cancer by
quantitative-multiplex polymerase chain reaction
AMERICAN JOURNAL OF PATHOLOGY 164 (1): 285-293 JAN 2004